Domača stran207940 • KRX
add
Samsung Biologics Co Ltd
Prejšnji trg. dan.
1.585.000,00 ₩
Dnevni razpon
1.551.000,00 ₩ - 1.631.000,00 ₩
Letni razpon
982.000,00 ₩ - 1.987.000,00 ₩
Tržna kapitalizacija
71,94 bil. KRW
Povprečni obseg
50,08 tis.
Razm. P/E
41,95
Dividendna donosnost
-
Borzne novice
The Motley Fool
pred 8 urami
Investing in an S&P 500 Index Fund? Beware of This Sneaky Risk Right Now.
0,11 %
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (KRW) | dec. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 1,45 bil. | 52,94 % |
Stroški poslovanja | — | — |
Čisti dohodek | — | — |
Čista dobičkovnost prihodkov | — | — |
Earnings per share | 8,72 tis. | 25,60 % |
EBITDA | — | — |
Efektivna davčna stopnja | — | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (KRW) | dec. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,46 bil. | 12,13 % |
Skupna sredstva | 11,06 bil. | −36,20 % |
Skupne obveznosti | 3,61 bil. | −43,88 % |
Celoten lastniški kapital | 7,45 bil. | — |
Shares outstanding | 54,52 mio. | — |
Razmerje P/B | 11,60 | — |
Donosnost sredstev | — | — |
Donosnost kapitala | — | — |
Denarni tok
Neto sprememba denarnih sredstev
| (KRW) | dec. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | — | — |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Generalni direktor
Datum ustanovitve
2011
Spletno mesto
Zaposleni
5.195
